Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Buy
5,525
+2,509
+83% +$520K 0.02% 461
2026
Q1
$677K Buy
3,016
+981
+48% +$244K 0.02% 488
2025
Q4
$490K Buy
2,035
+1,217
+149% +$311K 0.02% 464
2025
Q3
$224K Sell
818
-2,862
-78% -$782K 0.01% 661
2025
Q2
$949K Buy
+3,680
New +$878K 0.02% 361

Other funds holding RMD

SIG Brokerage's RMD Position: Q2 2026 in Review

SIG Brokerage increased its ResMed (RMD) stake by 83% in Q2 2026, buying an estimated $520K and bringing the position to 5,525 shares worth $1.08M. The position accounts for 0.02% of the portfolio, ranked #461.

SIG Brokerage first reported a position in RMD in Q2 2025 and has held it in 5 quarters since. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • SIG Brokerage held 5,525 shares of ResMed worth $1.08M as of Q2 2026.
  • SIG Brokerage bought 2,509 ResMed shares in Q2 2026, an estimated $520K.
  • ResMed made up 0.02% of SIG Brokerage's portfolio in Q2 2026, its #461 holding.
  • SIG Brokerage first reported a position in ResMed in Q2 2025 and has held it in 5 quarters since.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on SIG Brokerage's 13F filing for Q2 2026, filed 14 Aug 2026.